Amgen (NASDAQ:AMGN) shareholders have earned a 15% CAGR over the last five years

Investing for the long term aims to generate profit, with Amgen Inc. seeing a 73% share price increase in 5 years. However, EPS declined by 14% annually. Despite revenue growth, it's important to assess various metrics to gauge the company's performance.